As of June 4, 2025, CannaPharmaRx Inc (CPMD) reports a Gross Margin of 20.97%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Comparing CannaPharmaRx Inc's Gross Margin to Peers
To better understand CannaPharmaRx Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| CannaPharmaRx Inc (CPMD) | 20.97% |
| American Green Inc (ERBB) | 7775.20% |
| Nouveau Life Pharmaceuticals Inc (NOUV) | 7775.20% |
| Exmceuticals Inc (EXM.CN) | 7775.20% |
| NanoSphere Health Sciences Inc (NSHS.CN) | 7775.20% |
| RespireRx Pharmaceuticals Inc (RSPI) | 7775.20% |
Compared to its competitors, CannaPharmaRx Inc's Gross Margin is about average compared to peers, indicating industry-standard operational efficiency.